Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Se-methylselenocysteine on the Antioxidant System in Rat Tissues

  • Received : 2010.10.08
  • Accepted : 2010.11.26
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

We assessed the effect of Se-methylselenocysteine (MSC) treatment, at a dose of 0.75 mg/rat/day for 1 or 2 weeks, on the activities of antioxidant systems in Sprague-Dawley rat tissues. Significant changes in glutathione and antioxidant enzyme activities, with different patterns among tissues, were evidenced. Glutathione content and its reduction state in the liver, lung, and kidney were elevated upon MSC treatment, whereas they were significantly lowered in the spleen. Among the tissues exhibiting glutathione increase, there were different enzymatic responses: $\gamma$-glutamylcysteine ligase activity, the rate-limiting enzyme in the glutathione synthesis pathway, was increased in the liver, whereas the activities of the enzymes associated with glutathione recycling, namely, glutathione peroxidase, glutathione reductase, and glucose 6-phosphate dehydrogenase, were significantly increased in the lung and the kidney. The superoxide dismutase activity was decreased in all tissues upon MSC treatment, whereas catalase activity was increased in all tissues but the liver. Lipid peroxidation level was transiently increased at 1 week in the lung and the kidney, whereas it was persistently increased in the spleen. The increase was not evident in the liver. The results indicate that the MSC treatment results in an increase in the antioxidant capacity of the liver, lung, and kidney principally via an increase in glutathione content and reduction, which appeared to be a result of increased synthesis or recycling of glutathione via tissue-dependent adaptive response to oxidative stress triggered by MSC. The spleen appeared to be very sensitive to oxidative stress, and therefore, the adaptive response could not provide protection against oxidative damage.

Keywords

References

  1. Alissa EM, Bahijri SM, Ferns GA. 2003. The controversysurrounding selenium and cardiovascular disease: a reviewof the evidence. Med Sci Monit 9: RA9-18.
  2. Ellis DR, Salt DE. 2003. Plants, selenium and humanhealth. Curr Opin Plant Biol 6: 273-279. https://doi.org/10.1016/S1369-5266(03)00030-X
  3. Pagmantidis V, Meplan C, van Schothorst EM, Keijer J,Hesketh JE. 2008. Supplementation of healthy volunteerswith nutritionally relevant amounts of selenium increasesthe expression of lymphocyte protein biosynthesis genes.Am J Clin Nutr 87: 181-189.
  4. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, ChalkerDK, Chow J, Davis LS, Glover RA, Graham GF, GrossEG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr,Smith CL, Taylor JR. 1996. Effects of selenium supplementationfor cancer prevention in patients with carcinomaof the skin. A randomized controlled trial. NutritionalPrevention of Cancer Study Group. JAMA 276: 1957-1963. https://doi.org/10.1001/jama.276.24.1957
  5. Combs GF Jr, Gray WP. 1998. Chemopreventive agents:selenium. Pharmacol Ther 79: 179-192. https://doi.org/10.1016/S0163-7258(98)00014-X
  6. Ip C. 1998. Lessons from basic research in selenium andcancer prevention. J Nutr 128: 1845-1854.
  7. Sinha R, El-Bayoumy K. 2004. Apoptosis is a critical cellularevent in cancer chemoprevention and chemotherapyby selenium compounds. Curr Cancer Drug Targets 4: 13-28. https://doi.org/10.2174/1568009043481614
  8. Gartner R, Albrich W, Angstwurm MW. 2001. The effectof a selenium supplementation on the outcome of patientswith severe systemic inflammation, burn and trauma.Biofactors 14: 199-204. https://doi.org/10.1002/biof.5520140125
  9. Tirosh O, Levy E, Reifen R. 2007. High selenium dietprotects against TNBS-induced acute inflammation, mitochondrialdysfunction, and secondary necrosis in ratcolon. Nutrition 23: 878-886. https://doi.org/10.1016/j.nut.2007.08.019
  10. Azrak RG, Cao S, Pendyala L, Durrani FA, Fakih M,Combs GF Jr, Prey J, Smith PF, Rustum YM. 2007.Efficacy of increasing the therapeutic index of irinotecan,plasma and tissue selenium concentrations is methylselenocysteinedose dependent. Biochem Pharmacol 73:1280-1287. https://doi.org/10.1016/j.bcp.2006.12.020
  11. Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA,Burow ME, Rowan BG. 2009. Combination of methylselenocysteinewith tamoxifen inhibits MCF-7 breast cancerxenografts in nude mice through elevated apoptosisand reduced angiogenesis. Breast Cancer Res Treat 118:33-43. https://doi.org/10.1007/s10549-008-0216-x
  12. Irons R, Carlson BA, Hatfield DL, Davis CD. 2006. Bothselenoproteins and low molecular weight selenocompoundsreduce colon cancer risk in mice with genetically impairedselenoprotein expression. J Nutr 136: 1311-1317.
  13. Letavayova L, Vlckova V, Brozmanova J. 2006. Selenium:from cancer prevention to DNA damage. Toxicology 227:1-14. https://doi.org/10.1016/j.tox.2006.07.017
  14. Ip C, Birringer M, Block E, Kotrebai M, Tyson JF, UdenPC, Lisk DJ. 2000. Chemical speciation influences comparativeactivity of selenium-enriched garlic and yeast inmammary cancer prevention. J Agric Food Chem 48:2062-2070. https://doi.org/10.1021/jf000051f
  15. Whanger PD. 2002. Selenocompounds in plants and animalsand their biological significance. J Am Coll Nutr 21:223-232. https://doi.org/10.1080/07315724.2002.10719214
  16. Zeng H, Briske-Anderson M, Idso JP, Hunt CD. 2006.The selenium metabolite methylselenol inhibits the migrationand invasion potential of HT1080 tumor cells. J Nutr136: 1528-1532.
  17. Jackson MI, Combs GF Jr. 2008. Selenium and anticarcinogenesis:underlying mechanisms. Curr Opin Clin NutrMetab Care 11: 718-726. https://doi.org/10.1097/MCO.0b013e3283139674
  18. Zhuo H, Smith AH, Steinmaus C. 2004. Selenium and lungcancer: a quantitative analysis of heterogeneity in the currentepidemiological literature. Cancer Epidemiol BiomarkersPrev 13: 771-778.
  19. Nam TI, Park JJ, Choi EM. 2009. Prevention of alloxan-induced diabetes by Se-methylselenocysteine pretreatmentin rats: The effect on antioxidant system in pancreas.J Food Sci Nutr 14: 95-101. https://doi.org/10.3746/jfn.2009.14.2.095
  20. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW,Potter DW. 1980. High-performance liquid chromatographyanalysis of nanomole levels of glutathione, glutathionedisulfide, and related thiols and disulfides. AnalBiochem 106: 55-62. https://doi.org/10.1016/0003-2697(80)90118-9
  21. Seelig GF, Meister A. 1984. Gamma-glutamylcysteine synthetasefrom erythrocytes. Anal Biochem 141: 510-514. https://doi.org/10.1016/0003-2697(84)90079-4
  22. Paglia DE, Valentine WN. 1967. Studies on the quantitativeand qualitative characterization of erythrocyte glutathioneperoxidase. J Lab Clin Med 70: 158-169.
  23. Cohen MB, Duvel DL. 1988. Characterization of the inhibitionof glutathione reductase and the recovery of enzymeactivity in exponentially growing murine leukemia(L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.Biochem Pharmacol 37: 3317-3320. https://doi.org/10.1016/0006-2952(88)90645-4
  24. Bautista JM, Mason PJ, Luzzatto L. 1992. Purification andproperties of human glucose-6-phosphate dehydrogenasemade in E. coli. Biochim Biophys Acta 1119: 74-80. https://doi.org/10.1016/0167-4838(92)90237-8
  25. Misra HP, Fridovich I. 1972. The role of superoxide anionin the autoxidation of epinephrine and a simple assay forsuperoxide dismutase. J Biol Chem 247: 3170-3175.
  26. Aebi H. 1984. Catalase in vitro. Methods Enzymol 105:121-126. https://doi.org/10.1016/S0076-6879(84)05016-3
  27. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxidesin animal tissues by thiobarbituric acid reaction.Anal Biochem 95: 351-358. https://doi.org/10.1016/0003-2697(79)90738-3
  28. Mueller AS, Pallauf J, Rafael J. 2003. The chemical formof selenium affects insulinomimetic properties of the traceelement: investigations in type II diabetic dbdb mice. JNutr Biochem 14: 637-647. https://doi.org/10.1016/j.jnutbio.2003.08.001
  29. Park EM, Ramnath N, Yang GY, Ahn JY, Park YR, LeeTY, Shin HS, Yu JH, Ip C, Park YM. 2007. High superoxidedismutase and low glutathione peroxidase activitiesin red blood cells predict susceptibility of lung cancer patientsto radiation pneumonitis. Free Radic Biol Med 42:280-287. https://doi.org/10.1016/j.freeradbiomed.2006.10.044
  30. Pinho RA, Andrades ME, Oliveira MR, Pirola AC, ZagoMS, Silveira PCL, Dal-Pizzol F, Moreira JC. 2006. Imbalancein SOD/CAT activities in rat skeletal muscles submittedto treadmill training exercise. Cell Biol Int 30:848-853. https://doi.org/10.1016/j.cellbi.2006.03.011
  31. Lauterburg BH, Adams JD, Mitchell JR. 1984. Hepaticglutathione homeostasis in the rat: efflux accounts for glutathioneturnover. Hepatology 4: 586-590. https://doi.org/10.1002/hep.1840040402
  32. Lash LH, Jones DP. 1984. Renal glutathione transport.Characteristics of the sodium-dependent system in the basal-lateral membrane. J Biol Chem 259: 14508-14514.
  33. Kinnula VL, Paakko P, Soini Y. 2004. Antioxidant enzymesand redox regulating thiol proteins in malignanciesof human lung. FEBS Lett 569: 1-6. https://doi.org/10.1016/j.febslet.2004.05.045
  34. van Klaveren RJ, Demedts M, Nemery B. 1997. Cellularglutathione turnover in vitro, with emphasis on type IIpneumocytes. Eur Respir J 10: 1392-1400. https://doi.org/10.1183/09031936.97.10061392
  35. Drake EN. 2006. Cancer chemoprevention: selenium asa prooxidant, not an antioxidant. Med Hypotheses 67:318-322. https://doi.org/10.1016/j.mehy.2006.01.058
  36. Spallholz JE. 1997. Free radical generation by seleniumcompounds and their prooxidant toxicity. Biomed EnvironSci 10: 260-270.
  37. Calder PC. 1997. N-3 polyunsaturated fatty acids and immunecell function. Adv Enzyme Regul 37: 197-237. https://doi.org/10.1016/S0065-2571(96)00004-0